The
pellets were evaluated for physical properties namely, surface appearance, size
analysis, content uniformity, micromeritic properties, friability, infrared
spectroscopy, differential scanning calorimetry, scanning electron microscopy,
Feret diameter, aspect ratio, stability study and in vitro release studies.
Based on in vitro release studies and SEM analysis, pellets containing 2.5% PVP
K-30 were found to be optimized for coating. The drug was compatible when mixed
with excipients, which was confirmed by IR spectroscopy and differential
scanning calorimetry. Pellets showed good micromeritic properties. Further, in
vitro release study of coated pellets revealed optimum lag-time (6±0.25 h)
before drug release and Eudragit® S100 with 25% weight gain was optimized.
There was no significant change in the drug content and release profile of the
pellets stored under accelerated conditions. Thus the multiparticulate delivery
system of valsartan found to be suitable as potential chronomodulated drug
delivery system to treat early morning surge in hypertensive patients.
Website: http://www.arjonline.org/medicine-and-health-care/american-research-journal-of-pharmacy/
Website: http://www.arjonline.org/medicine-and-health-care/american-research-journal-of-pharmacy/
No comments:
Post a Comment